Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;8(6):2416-2424.
doi: 10.21037/tcr.2019.09.50.

TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy

Affiliations

TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy

Shuyu Zhai et al. Transl Cancer Res. 2019 Oct.

Abstract

Background: Pancreatic cancer is a highly aggressive cancer featured by early metastasis and multiple chemoresistance. Surgical resection remains the only way for the radical cure of pancreatic cancer. The aim of this study was to assess the safety, feasibility and oncological effect of the Heidelberg TRIANGLE operation in total pancreatectomy (TP) for borderline resectable pancreatic cancer (BRPC).

Methods: Patients with BRPC eligible for TP were selected and underwent total pancreatectomy with Heidelberg TRIANGLE operation. Sharp dissection was applied to separate tumor and involved artery. Then we completely dissected the soft tissues surround celiac axis (CA) and superior mesenteric artery (SMA) in each case. If superior mesenteric vein (SMV) or portal vein (PV) were invaded by the tumor, resection and reconstruction of veins were performed. Operation time, blood loss, post-operative complications, perioperative mortality, number of lymph node examined and R0 resection rate were collected and analyzed.

Results: Nine BRPC patients underwent TRIANGLE operation in TP. No perioperative death occurred. 3 cases developed postoperative complications: biliary leakage and colon fistula in 1 case and lymphatic leakage in 2 cases. The R0 resection rate of operation was 88.89% (8/9).

Conclusions: For patients with BRPC, upfront surgery should be encouraged when they were unwilling or unable to received neoadjuvant therapy. Especially for those patients with artery involvement eligible for TP, TRIANGLE operation can help to achieve arterial sparing resection. Thus, the risk of postoperative hemorrhage for vascular reconstruction and skeletonization can be reduced. After postoperative adjuvant therapy, the prognosis is acceptable.

Keywords: Pancreatic cancer; general surgery; pancreatectomy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2019.09.50). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
CT scan of patients eligible for TRIANGLE operation.
Figure 2
Figure 2
Pictures taken during surgery. The triangle indicates CA, SMA and PV/SMV, which are involved in TRIANGLE operation. CA, celiac axis; SMA, superior mesenteric artery; SMV, superior mesenteric vein; PV, portal vein.
Figure 3
Figure 3
Perioperative data collected in recent years and in TRIANGLE operation. (A) Operating time, (B) blood loss, (C) lymph node number and (D) number of positive lymph node.

References

    1. Lin QJ, Feng Y, Chen J, et al. Current status and progress of pancreatic cancer in China. World J Gastroenterol 2015;21:7988-8003. 10.3748/wjg.v21.i26.7988 - DOI - PMC - PubMed
    1. Sabater L, Muñoz E, Roselló S, et al. Borderline resectable pancreatic cancer. Challenges and controversies. Cancer Treat Rev 2018;68:124-35. 10.1016/j.ctrv.2018.06.006 - DOI - PubMed
    1. Varadhachary GR, Tamm EP, Abbruzzese JL, et al. BRPC: Definitions, Management, and Role of Preoperative Therapy. Ann Surg Oncol 2006;13:1035-46. 10.1245/ASO.2006.08.011 - DOI - PubMed
    1. Hackert T, Strobel O, Michalski CW, et al. The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study. HPB (Oxford) 2017;19:1001-7. 10.1016/j.hpb.2017.07.007 - DOI - PubMed
    1. Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017;15:1028-61. 10.6004/jnccn.2017.0131 - DOI - PubMed